PHARMACODYNAMICS OF VORAPAXAR, A PLATELET PAR-1 ANTAGONIST, AND ITS INTERACTION WITH P2Y12 RECEPTOR PATHWAY IN THE TRACER TRIAL
Jennings L, Moliterno D, Storey R, Hord E, Kotha J, Becker R, Smyth S, Providencia L, Moccetti T, Valgimigli M, Dery J, Cornel J, Thomas G, Huber K, Chen E, Strony J, Rorick T, Tricoci P, Mahaffey K. PHARMACODYNAMICS OF VORAPAXAR, A PLATELET PAR-1 ANTAGONIST, AND ITS INTERACTION WITH P2Y12 RECEPTOR PATHWAY IN THE TRACER TRIAL. Journal Of The American College Of Cardiology 2012, 59: e351. DOI: 10.1016/s0735-1097(12)60352-0.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply